Vaccinex, Inc.
NASDAQ:VCNX
4.55 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1.535 | 6.391 | 8.589 | 10.596 | 2.776 | 5.618 | 4.18 | 1.661 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 14.106 | 0 | 0 |
| Cash and Short Term Investments
| 1.535 | 6.391 | 8.589 | 10.596 | 2.776 | 19.724 | 4.18 | 1.661 |
| Net Receivables
| 0.961 | 0.175 | 0 | 0.157 | 0.898 | 0.639 | 0.117 | 0.104 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.853 | 0.912 | 0.816 | 0.533 | 0.336 | 1.061 | 0.677 | 0.347 |
| Total Current Assets
| 3.349 | 7.478 | 9.405 | 11.286 | 4.01 | 21.424 | 4.974 | 2.112 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 0.282 | 0.499 | 0.438 | 0.416 | 0.594 | 0.604 | 0.601 | 0.73 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -0 | -0.499 | -0.438 | -0.416 | -0.594 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0.282 | 0.499 | 0.438 | 0.416 | 0.594 | 0.604 | 0.601 | 0.73 |
| Total Assets
| 3.631 | 7.977 | 9.843 | 11.702 | 4.604 | 22.028 | 5.575 | 2.842 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 2.039 | 1.518 | 1.061 | 3.169 | 3.208 | 2.322 | 1.91 | 2.456 |
| Short Term Debt
| 0.221 | 0.238 | 0.215 | 8.074 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.063 | 0 | 0 | 0 | 0 | 0 | 0.298 | 0 |
| Other Current Liabilities
| 3.593 | 0.781 | 0.98 | 1.937 | 3.67 | 4.364 | 1.957 | 1.984 |
| Total Current Liabilities
| 5.916 | 2.537 | 2.256 | 13.18 | 6.878 | 6.686 | 4.165 | 4.44 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0.026 | 0.247 | 0.175 | 1.134 | 0 | 0 | 2.813 | 1.037 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -0 | 0 | -0.175 | -1.134 | 3.67 | 0 | 0.369 | 0.694 |
| Total Non-Current Liabilities
| 0.026 | 0.247 | 0.175 | 1.134 | 3.67 | 0 | 3.182 | 1.731 |
| Total Liabilities
| 5.942 | 2.784 | 2.431 | 14.314 | 6.878 | 6.686 | 7.347 | 6.171 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 4.604 | 0 | 119.402 | 111.42 |
| Common Stock
| 0 | 0.005 | 0.003 | 0.003 | 0.001 | 0.001 | 0 | 0.001 |
| Retained Earnings
| -339.927 | -319.676 | -299.861 | -277.481 | -248.63 | -216.767 | -187.249 | -168.527 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | -0 | 0 | -4.604 | -6.324 | -6.101 | -5.895 |
| Other Total Stockholders Equity
| 337.627 | 324.864 | 307.27 | 250.903 | 222.392 | 214.469 | 60.213 | 59.672 |
| Total Shareholders Equity
| -2.311 | 5.193 | 7.412 | -26.575 | -26.237 | -8.621 | -13.735 | -3.329 |
| Total Equity
| -2.311 | 5.193 | 7.412 | -2.612 | -2.274 | 15.342 | -1.772 | -3.329 |
| Total Liabilities & Shareholders Equity
| 3.631 | 7.977 | 9.843 | 11.702 | 4.604 | 22.028 | 5.575 | 2.842 |